Fig. 7

Antigastric cancer efficacy of GNP theranostic nanomedicines during treatment in vivo. a The survival rates (%) of the three groups of induced gastric cancer mice during 40 days treatment in the ten mice in each group and b the changes in body weight of different groups of mice over the period of 15 days observations